Brusilovsky, Michael
Rochman, Mark http://orcid.org/0000-0002-0818-927X
Rochman, Yrina http://orcid.org/0000-0002-1129-5946
Caldwell, Julie M. http://orcid.org/0000-0002-3855-299X
Mack, Lydia E.
Felton, Jennifer M.
Habel, Jeff E.
Porollo, Aleksey
Pasare, Chandrashekhar http://orcid.org/0000-0002-8142-2488
Rothenberg, Marc E. http://orcid.org/0000-0001-9790-6332
Article History
Received: 3 December 2020
Accepted: 22 July 2021
First Online: 16 September 2021
Competing interests
: M.E.R. is a consultant for Pulm One, Spoon Guru, ClostraBio, Serpin Pharm, Allakos, Celgene, Astra Zeneca, Adare/Ellodi Pharma, Glaxo Smith Kline, Regeneron/Sanofi, Revolo Biotherapeutics and Guidepoint, and has an equity interest in the first five listed, and royalties from reslizumab (Teva Pharmaceuticals), PEESSv2 (Mapi Research Trust) and UpToDate. M.E.R. is an inventor of patents owned by Cincinnati Children’s Hospital. The remaining authors declare no competing interests.